The use of genetically engineered mice in cancer prevention research.

被引：0
|
作者：
Marks, CL [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2005年 / 14卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2705S / 2706S
页数：2
相关论文
共 50 条
  • [41] Cancer research.
    不详
    LANCET, 1902, 1 : 1547 - 1548
  • [42] Cancer research.
    Murray, JA
    NATURE, 1925, 116 : 135 - 135
  • [43] Cancer research.
    不详
    LANCET, 1902, 1 : 1121 - 1122
  • [44] Statistical methods for the identification and validation of biomarkers in cancer prevention research.
    Feng, ZD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1241S - 1241S
  • [45] Congenital Hydrocephalus in Genetically Engineered Mice
    Vogel, P.
    Read, R. W.
    Hansen, G. M.
    Payne, B. J.
    Small, D.
    Sands, A. T.
    Zambrowicz, B. P.
    VETERINARY PATHOLOGY, 2012, 49 (01) : 166 - 181
  • [46] Genetically engineered mice in drug development
    Livingston, JN
    JOURNAL OF INTERNAL MEDICINE, 1999, 245 (06) : 627 - 635
  • [47] Mammary pathology of genetically engineered mice
    Howard B.
    Breast Cancer Research, 2 (1)
  • [48] Interpretation of phenotype in genetically engineered mice
    Doetschman, T
    LABORATORY ANIMAL SCIENCE, 1999, 49 (02): : 137 - 143
  • [49] Hepatic pathology in genetically engineered mice
    Dagli, MLZ
    Ward, JM
    Merlino, G
    Enomoto, A
    Maronpot, RR
    PATHOLOGY OF GENETICALLY ENGINEERED MICE, 2000, : 317 - 335
  • [50] Clinical evaluation of genetically engineered mice
    Devor-Henneman, DE
    PATHOLOGY OF GENETICALLY ENGINEERED MICE, 2000, : 145 - 154
12345